| Application no. and date | 14717294.4 (espacenet) (Federated) (European Patent Register), 20140312 | | Patent/reg. no. and date | DK/EP 2970473, 20170816 | | Publication date | 20160120 | | Priority no. and date | US 201361783184 P, 20130314 | | EP pub. no. and date |
EP 2970473 20160120 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V142282 | | Inventor | BARNHART, Bryan, Route 206&Province Line Road
Princeton, NJ 08543, US,
JURE-KUNKEL, Maria, N., Route 206&Province Line Road
Princeton, NJ 08543, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07K 16/28 (2006.01) | | Title | KOMBINATION AF DR5-AGONIST OG ANTI-PD-1-ANTAGONIST OG FREMGANGSMÅDER TIL ANVENDELSE HERAF | | Int. application no. | US2014024208 | | Int. publication no. | WO2014159562 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
